Please login to the form below

The changing face of pharma in the precision era

Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way.

The changing face of pharma in the precision era

NATASHA COWAN|6TH SEPTEMBER 2019

Nancy Brandt is not your typical medical information specialist. While medical affairs teams are usually focused on developing scientific communications about a product or service for healthcare professionals, she has been tasked with preparing a top 20 biopharma company for the future of precision medicine.

For pharma, it’s clear the future lies in making the right partnerships. Precision medicine equates understanding the patient’s molecular makeup and using this information and other clinical data to find targeted treatments. However, right now the policies and regulations are still being written. New stakeholders are entering the fray and bringing with them novel technologies that can improve patient outcomes.

We are on the brink of a new way of practising medicine and pharmaceutical companies have the opportunity to shape this future, but this hinges on collaborating with the right people and listening to what the complex network of stakeholders are asking of them.

This means moving away from a product-specific way of thinking to develop a deep insight into how society is changing as precision medicines emerge. As a result, Nancy is immersed in understanding the patient journey and developing agile ways of working to ensure the organisation stays one step ahead of novel developments. Armed with this information, she can then develop partnerships that will fuel innovative communications for the 21st-century patient and the complex stakeholder network, from doctors to policymakers.

Here, she reveals how she is embracing this new way of working and the lessons she has learned along the way.

DOWNLOAD THE ARTICLE HERE

6th September 2019

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance treatment and improve patient and stakeholder outcomes.
Blue Latitude Health
The changing face of pharma in the precision era
Blue Latitude Health speaks to Nancy Brandt, a Senior Leader in Global Medical Information at a top 20 biopharma organisation. Here, she reveals what pharmaceutical companies need to do to prepare to bring precision medicines to market and how she is ensuring the patient is consulted every step of the way.
Blue Latitude Health
Creative problem solving, solved
Customer Experience Consultant Eimear Power explains how pharma teams can unlock their creativity and foster truly innovative ideas.
Blue Latitude Health
Three strategies for managing loss of exclusivity successfully
Claire Taylor, Senior Associate Consultant at Blue Latitude Health explains why you should be strategically planning your LOE strategy years in advance.
Blue Latitude Health
Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to make a more accurate treatment decision. Here we discuss the barriers, opportunities and potential outcomes of the precision medicine era in healthcare.
Blue Latitude Health
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist and Director of Public Health at Genomics England, to find out how the NHS is achieving this goal.
Blue Latitude Health